MedicaidPrior AuthLow impact
Thrombate III® [Antithrombin III (Human)] (New)
Humana·IN · Hematology, Critical Care, OB-GYN +2 more·Medicaid
Effective date
Aug 27, 2025
We identified it
Jun 24, 2026
Summary
Humana Medicaid Indiana has implemented a new prior authorization requirement for Thrombate III (Antithrombin III), used to treat hereditary antithrombin deficiency. Prior authorization is required for both treatment of thromboembolism and prevention of peri-operative/peri-partum thromboembolism in patients with this rare genetic condition.
Action Required
By August 27, 2025: Billing team must update prior authorization procedures for Thrombate III when billing Humana Medicaid Indiana members. Ensure providers document hereditary antithrombin deficiency diagnosis and specify use for thromboembolism treatment or peri-operative/peri-partum prevention. Submit prior authorization requests before administration to avoid claim denials.